Related Experiment Video
Updated: Aug 13, 2026
07:03
Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo
Published on: April 6, 2015
[Uterine activity under tocolysis through a beta-sympathomimetic (author's transl)]
Zeitschrift Fur Geburtshilfe Und Perinatologie
|June 1, 1976
Summary
Beta-mimetic drugs can stop labor, but their in vitro effects differ from clinical outcomes. Tocolysis appears to disrupt the natural coordination of uterine activity during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
- Reproductive Physiology
Context:
- The mechanism of beta-mimetic tocolysis remains unclear.
- In vitro studies show differing effects of tocolytic agents on myometrial activity compared to clinical efficacy.
- Calcium channel blockers relax myometrium in vitro but are clinically ineffective for preterm labor.
Purpose:
- To investigate the mechanism of tocolysis by observing uterine activity during therapy.
- To differentiate the effects of beta-mimetics from Ca++ antagonists on uterine contractions.
- To understand how tocolytic agents alter the natural progression of uterine activity in pregnancy.
Summary:
- Uterine activity was monitored using external tocography during tocolytic therapy.
- Unlike normal pregnancy, tocolysis did not show an increase in Braxton-Hicks contractions and inactivity phases, nor a decrease in Alvarez waves.
- Tocolytic therapy was observed to inhibit the natural coordination process of uterine activity.
Impact:
- Findings suggest tocolysis may act by disturbing the coordination of uterine activity rather than direct myometrial relaxation.
- This research provides insights into the differential effects of tocolytic agents in vitro versus in vivo.
- Understanding the mechanism of tocolysis can inform the development of more effective preterm labor management strategies.
More Related Videos
07:56Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
Published on: January 26, 2018
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
Related Concept Videos
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:27Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...